Cognitive deficits are a core feature of schizophrenia, account for much of the impaired
functioning associated with the disorder and are not responsive to existing treatments. In this …

Schizophrenia is a major mental illness characterized by positive and negative symptoms,
and by cognitive deficit. Although cognitive impairment is disabling for patients, it has been …

Background Cognitive impairment are among the core features of schizophrenia,
experienced by up to 75% of patients. Available treatment options for schizophrenia …

Globally, methamphetamine is one of the most widely used illicit substances. Despite this,
there are no Food and Drug Administration (FDA)-approved pharmacotherapies for treating …

Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects over 1%
of population over age 60. It is defined by motor and nonmotor symptoms including a …

Abstract Development of novel treatments for positive, cognitive, and negative symptoms
continue to be a high‐priority area of schizophrenia research and a major unmet clinical …

TOBACCO USE DISORDER AND DUAL DISORDERS Page 1 TOBACCO USE DISORDER
AND DUAL DISORDERS Joint statement by the Spanish Psychiatry Society and the …

Schizophrenia is a heterogeneous disorder that usually has an onset in the second decade
of life and often runs a chronic course. Traditionally, schizophrenia is characterized by …

Background Smoking in patients with Schizophrenia is more common than in the general
population. Varenicline, a partial agonist at α4β2 nicotinic acetylcholine receptors, is an …

Context• Schizophrenia is a common and clinically disabling mental disorder. Many patients
with schizophrenia smoke. Research on the effects of smoking on schizophrenia's symptoms …